The “2023 Glaucoma Surgical Device Market Report” analyzes a new trend in the treatment of glaucoma patients: earlier surgical intervention. The report projects market growth through 2028 and discusses the mix of combination cataract/glaucoma surgeries and standalone glaucoma procedures for eight regions of the world.
Glaucoma laser technologies in development or early commercialization are expected to significantly increase overall laser penetration. The new report highlights some of these technologies, including the Belkin laser, ViaLase femtosecond laser, Elios excimer laser, and IOPtimate CO2 laser.
Surgical device options in the past few years have more than doubled, and rapid expansion is expected to continue over the next five years, based on the number of new devices in development. The report analyzes this growing number of products from each competitor and illustrates the expected increase by type. It also tracks the progress being made in sustained drug delivery devices in a separate section.
A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.